Chordia Therapeutics: Quarterly Report - 7th Quarter 3rd Quarter (2024/03/01 - 2024/05/31)
Chordia Therapeutics: Confirmation letter
Chordia Therapeutics: Third quarter financial results for August 2024 term, based on Japanese standards (non-consolidated).
Chordia Therapeutics: Unconsolidated financial results [Japan standard] for the nine months ended May 31, 2024.
Chordia Therapeutics: Announcements of individual stock regarding the results of third-party allocation of capital increase.
Chordia Therapeutics: Exhibited at the 19th Nikkei IR and Individual Investor Fair in 2024.
Chordia Therapeutics: Received the Mizuho Innovation Award 2024.2Q, which was sponsored by Mizuho Bank.
Chordia Therapeutics: Report on a large shareholding
Chordia Therapeutics: Report on a large shareholding
Chordia Therapeutics: Report on a large shareholding
Chordia Therapeutics: Report on a large shareholding
Chordia Therapeutics: Large shareholding reports (special exception share certificates, etc.)
Chordia Therapeutics: Report on a large shareholding
Chordia Therapeutics: Independent Company Executives Declaration
Chordia Therapeutics: Report on Corporate Governance - June 14, 2024.
Chordia Therapeutics: Articles of Association February 29, 2024
Chordia Therapeutics: Matters related to business plans and growth potential.
Chordia Therapeutics: Announcements of individual stocks regarding our financial information etc. due to our listing on the Tokyo Stock Exchange Growth Market.
Chordia Therapeutics: Correction Securities Registration Statement (At the time of initial public offering).
Chordia Therapeutics Inc.: (Additional) Revised securities report for listing application
No Data